NYMC Faculty Publications

Development of Human Prostate Cancer Stem Cells Involves Epigenomic Alteration and PI3K/AKT Pathway Activation

Journal Title

Experimental Hematology and Oncology

First Page

12

Last Page

12

Document Type

Article

Publication Date

6-2020

Department

Medicine

Abstract

BACKGROUND: Human prostate cancer spheres endowed with stem cell properties have been obtained from androgen-dependent cell line LNCaP after exposure to an epigenomic modulator phenethyl isothiocynate (PEITC). Sphere cells can self-renew and grow with androgen, and also without androgen. Little is known about the signaling pathway and mechanism in the development of the stem cells in the spheres.

METHODS: Expression of phosphoinositol-3 kinase (PI3K) pathway members and histone acetylation were quantified in the tumor spheres and LNCaP cells by western immunoblotting.

RESULTS: The level of phosphorylated AKT was significantly increased in the sphere stem cells than the LNCaP cells at an average of 7.4 folds (range 5.8-10.7 folds), whereas the P27 level was elevated 5.4 folds (range 4.8-6.3 folds) (

CONCLUSIONS: PEITC appears to regulate the epigenome through histone acetylation and activate the PI3K/AKT pathway in the LNCaP cells. This mechanism may be responsible in part for the development of the prostate cancer stem cells.

This document is currently not available here.

Share

COinS